Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AN2 Therapeutics, Inc. - Common Stock
(NQ:
ANTX
)
7.530
+1.120 (+17.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AN2 Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
AN2 Therapeutics to Present at Jefferies Healthcare Conference
May 25, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 16, 2023
Via
Benzinga
AN2 Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Present at JMP Securities Life Sciences Conference
May 01, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 29, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Dip
January 27, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
November 14, 2022
Keybanc boosted the price target on Lennar Corporation (NYSE: LEN) from $89 to $100. Lennar shares fell 0.4% to close at $88.03 on Friday.
Via
Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 09, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 02, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
October 19, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
October 12, 2022
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
October 06, 2022
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
September 29, 2022
NIAID Agreement to Advance Development of Epetraborole for Acute Systemic Melioidosis
From
AN2 Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Gainers
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Gainers
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Via
Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
August 30, 2022
U.S. stocks extended losses toward the end of trading, with the Nasdaq Composite dropping around 200 points on Tuesday
Via
Benzinga
How Is The Market Feeling About AN2 Therapeutics?
August 15, 2022
AN2 Therapeutics (NASDAQ:ANTX) short percent of float has risen 4.76% since its last report. The company recently reported that it has 194 thousand shares sold short,...
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 01, 2022
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 18, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 18, 2022
Good morning, investors! We're back at it this week with a breakdown of the biggest pre-market stock movers to watch on Monday!
Via
InvestorPlace
Boeing And 24 Stocks Moving Premarket
July 18, 2022
Gainers Qudian Inc. (NYSE: QD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.